Increased muscle expression of interleukin-17 in Duchenne muscular dystrophyDE PASQUALE, L; D'AMICO, A; VERARDO, M et al.Neurology. 2012, Vol 78, Num 17, pp 1309-1314, issn 0028-3878, 6 p.Article

The burden of Duchenne muscular dystrophy: An international, cross-sectional studyLANDFELDT, Erik; LINDGREN, Peter; BELL, Christopher F et al.Neurology. 2014, Vol 83, Num 6, pp 529-536, issn 0028-3878, 8 p.Article

Can outcomes in Duchenne muscular dystrophy be improved by public reporting of data?SCULLY, Michele A; CWIK, Valerie A; MARSHALL, Bruce C et al.Neurology. 2013, Vol 80, Num 6, pp 583-589, issn 0028-3878, 7 p.Article

Neurocognitive Profiles in Duchenne Muscular Dystrophy and Gene Mutation SiteD'ANGELO, Maria Grazia; LORUSSO, Maria Luisa; CIVATI MA, Federica et al.Pediatric neurology. 2011, Vol 45, Num 5, pp 292-299, issn 0887-8994, 8 p.Article

Gentamicin-Induced Readthrough of Stop Codons in Duchenne Muscular DystrophyMALIK, Vinod; RODINO-KLAPAC, Louise R; HAYES, John et al.Annals of neurology. 2010, Vol 67, Num 6, pp 771-780, issn 0364-5134, 10 p.Article

Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophyESCOLAR, D. M; HACHE, L. P; PESTRONK, A et al.Neurology. 2011, Vol 77, Num 5, pp 444-452, issn 0028-3878, 9 p.Article

T2 Mapping in Duchenne Muscular Dystrophy: Distribution of Disease Activity and Correlation with Clinical AssessmentsHEE KYUNG KIM; LAOR, Tal; HORN, Paul S et al.Radiology. 2010, Vol 255, Num 3, pp 899-908, issn 0033-8419, 10 p.Article

Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort studyMAZZONE, E; VASCO, G; FROSINI, S et al.Neurology. 2011, Vol 77, Num 3, pp 250-256, issn 0028-3878, 7 p.Article

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophyPEGORARO, E; HOFFMAN, E. P; LANFRANCHI, G et al.Neurology. 2011, Vol 76, Num 3, pp 219-226, issn 0028-3878, 8 p.Article

Disability and survival in Duchenne muscular dystrophyKOHLER, M; CLARENBACH, C. F; BAHLER, C et al.Journal of neurology, neurosurgery and psychiatry. 2009, Vol 80, Num 3, pp 320-325, issn 0022-3050, 6 p.Article

Deflazacort Use in Duchenne Muscular Dystrophy : An 8-Year Follow-UpHOUDE, Sylvie; FILIATRAULT, Michèle; FOURNIER, Anne et al.Pediatric neurology. 2008, Vol 38, Num 3, pp 200-206, issn 0887-8994, 7 p.Article

Actualités thérapeutiques dans la myopathie de Duchenne = Therapeutic update of Duchenne muscular dystrophyDESGUERRE, Isabelle; BARNERIAS, Christine.MTP. Médecine thérapeutique pédiatrie. 2014, Vol 17, Num 3, pp 179-184, issn 1286-5494, 6 p.Article

Evidence-Based Path to Newborn Screening for Duchenne Muscular DystrophyMENDELL, Jerry R; SHILLING, Chris; HAMIL, Cindy et al.Annals of neurology. 2012, Vol 71, Num 3, pp 304-313, issn 0364-5134, 10 p.Article

Permanent muscular sodium overload and persistent muscle edema in Duchenne muscular dystrophy: a possible contributor of progressive muscle degenerationWEBER, M.-A; NAGEL, A. M; WOLF, M. B et al.Journal of neurology. 2012, Vol 259, Num 11, pp 2385-2392, issn 0340-5354, 8 p.Article

Exon Skipping Quantification by Quantitative Reverse-Transcription Polymerase Chain Reaction in Duchenne Muscular Dystrophy Patients Treated with the Antisense Oligomer EteplirsenANTHONY, Karen; FENG, Lucy; ARECHAVALA-GOMEZA, Virginia et al.Human gene therapy. Part B. Methods (Print). 2012, Vol 23, Num 5, pp 336-345, issn 1946-6536, 10 p.Article

Responsiveness of the Motor Function Measure in Neuromuscular DiseasesVUILLEROT, Carole; PAYAN, Christine; GIRARDOT, Françoise et al.Archives of physical medicine and rehabilitation (Print). 2012, Vol 93, Num 12, pp 2251-2256, issn 0003-9993, 6 p.Article

PRESERVATION OF MUSCLE SPINDLES IN A 27-YEAR-OLD DUCHENNE MUSCULAR DYSTROPHY PATIENT: IMPORTANCE FOR REGENERATIVE MEDICINE STRATEGIESSKUK, Daniel; GOULET, Marlyne; TREMBLAY, Jacques P et al.Muscle & nerve. 2010, Vol 41, Num 5, pp 729-730, issn 0148-639X, 2 p.Article

Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophyMARTIGNE, L; SEGUY, D; PELLEGRINI, N et al.Clinical nutrition (Edinburgh). 2010, Vol 29, Num 1, pp 60-64, issn 0261-5614, 5 p.Article

Impact of Steroids on Surgical Experiences of Patients With Duchenne Muscular DystrophyDOOLEY, Joseph M; GORDON, Kevin E; MACSWEEN, Judith M et al.Pediatric neurology. 2010, Vol 43, Num 3, pp 173-176, issn 0887-8994, 4 p.Article

Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatmentCOLUSSI, C; BANFI, C; BRIOSCHI, M et al.Proteomics. Clinical applications (Print). 2010, Vol 4, Num 1, pp 71-83, issn 1862-8346, 13 p.Article

Targeting Fibrosis in Duchenne Muscular DystrophyLAN ZHOU; HAIYAN LU.Journal of neuropathology and experimental neurology. 2010, Vol 69, Num 8, pp 771-776, issn 0022-3069, 6 p.Article

Delayed Diagnosis in Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)CIAFALONI, Emma; FOX, Deborah J; CUNNIFF, Christopher et al.The Journal of pediatrics. 2009, Vol 155, Num 3, pp 380-385, issn 0022-3476, 6 p.Article

Airway Clearance in Duchenne Muscular DystrophyKRAVITZ, Richard M.Pediatrics (Evanston). 2009, Vol 123, issn 0031-4005, S231-S235, SUP4Conference Paper

An Undiagnosed Cytogenetic Abnormality Results in the Misidentification of a Duchenne Muscular Dystrophy CarrierGILLAN, Tanya L; DAVIES, Christine; INNES, A. Micheil et al.American journal of medical genetics. Part A. 2008, Vol 146, Num 8, pp 1067-1071, issn 1552-4825, 5 p.Article

Successful cardiac resynchronisation therapy in Duchenne muscular dystrophy: A 5-year follow-upFAYSSOIL, Abdallah; NARDI, Olivier; ANNANE, Djillali et al.La Presse médicale (1983). 2014, Vol 43, Num 3, pp 330-331, issn 0755-4982, 2 p.Article